Instead of inhibiting Myc’s transcriptional activity like most inhibitors, DL78 acts as a Myc modulator, utilizing Myc’s interaction with α-tubulin and its role in regulating mitotic fate to selectively target and eliminate cancer cells with high Myc expression. This evidence concerns the gene MYC and cancer.